Sulfadiazine: Difference between revisions
Content deleted Content added
rm remarks about toxoplasma and cat litter, etc. off topic for sulfadiazine. |
cosmetics |
||
Line 1: | Line 1: | ||
{{Drugbox| |
{{Drugbox| |
||
|IUPAC_name = 4-amino-N-pyrimidin- 2-yl-benzenesulfonamide |
|IUPAC_name = 4-amino-''N''-pyrimidin- 2-yl-benzenesulfonamide |
||
| image=Sulfadiazine-2D-skeletal.png |
| image=Sulfadiazine-2D-skeletal.png |
||
| width=250 |
| width=250 |
Revision as of 20:01, 1 August 2009
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Cream |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Elimination half-life | ? |
Excretion | ? |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.623 |
Chemical and physical data | |
Formula | C10H10N4O2S |
Molar mass | 250.278 g/mol g·mol−1 |
Sulfadiazine is a sulfonamide antibiotic.
Uses
It eliminates bacteria that cause infections by stopping the production of folic acid inside the bacterial cell, and is commonly used to treat urinary tract infections (UTIs).
In combination, sulfadiazine and pyrimethamine, can be used to treat toxoplasmosis, a disease caused by Toxoplasma gondii.
Side effects
Side effects reported for sulfadiazine include: nausea, upset stomach, loss of appetite, and dizziness.
Brand names
Lantrisul; Neotrizine; Sulfa-Triple #2; Sulfadiazine; Sulfaloid; Sulfonamides Duplex; Sulfose; Terfonyl; Triple Sulfa; Triple Sulfas; Triple Sulfoid
See also
External links
- Sulfadiazine (patient information)